Yiyang Yu - Publications

An open-label, two-cohort, phase 1a/b study of weekly irinotecan hydrochloride liposome injection combined with vincristine and temozolomide (NALIRI-VT) in patients with advanced Ewing sarcoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 02, 2026

Machine learning-based integrative analysis identifies CXCL13-driven tertiary lymphoid structures as favorable immune and prognostic features in osteosarcoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: December 27, 2025

sB7-H3 as a prognostic biomarker in osteosarcoma: insights into clinical outcomes.

Journal: Scientific reports

Published: December 06, 2025

The relevance of B7-H3 and tumor-associated macrophages in the tumor immune microenvironment of solid tumors: recent advances.

Journal: American journal of translational research

Published: September 14, 2024

Intraoperative Resection Guidance and Rapid Pathological Diagnosis of Osteosarcoma using B7H3 Targeted Probe under NIR-II Fluorescence Imaging.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 24, 2023

Two-step osteotomy/discectomy through cannulated screw (TOCS) technique for en bloc resection of spine tumor: surgical technique and preliminary results.

Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

Published: September 30, 2023

Chordoma recruits and polarizes tumor-associated macrophages via secreting CCL5 to promote malignant progression.

Journal: Journal for immunotherapy of cancer

Published: March 27, 2023

The COPS3-FOXO3 positive feedback loop regulates autophagy to promote cisplatin resistance in osteosarcoma.

Journal: Autophagy

Published: December 01, 2022

Immune-Related LncRNAs Affect the Prognosis of Osteosarcoma, Which Are Related to the Tumor Immune Microenvironment.

Journal: Frontiers in cell and developmental biology

Published: June 26, 2021

The role of tumor-associated macrophages in osteosarcoma progression - therapeutic implications.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: February 16, 2021

Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis.

Journal: Cancer cell international

Published: January 05, 2021

Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.

Journal: Aging

Published: November 28, 2020